• 

  06.19.13

  U-M Cancer Center names Alon Weizer new medical director

  Dr. Weizer is associate professor of urology at the U-M Medical School. His clinical and research interest focuses on prevention and early detection of bladder cancer, novel treatments for early bladder cancer, and the use of minimally invasive approaches to treat bladder, prostate, kidney, testicular and other genitourinary malignancies. He is also interested in the development of quality indicators for cancer care.
  
  His appointment is effective on June 17.
• 

  06.13.13

  Study finds cancer guidelines do not fully meet IOM standards

  Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical practice guidelines for lung, breast, prostate and colorectal cancers and found that none of the guidelines fully met standards set in 2011 by the Institute of Medicine. Of eight criteria, the guidelines on average met fewer than three.
• 

  06.12.13

  Ten things to know about esophageal cancer and African American men

  The nation's attention and research money has been focused on esophageal adenocarcinoma – the type of esophageal cancer that has become more common over the last few decades and is associated with obesity and acid reflux.

  But another type of cancer of the esophagus is a serious threat to African American men, especially if they drink and smoke.
• 

  06.10.13

  A path to lower-risk painkillers: Newly-discovered drug target paves way for alternatives to morphine

  New findings provide vital step towards exploring pain medications that may lower risks of prescription drug abuse and side effects of painkillers.

More 2013 releases